SILO Rentabilitas reged Silo Pharma, Inc.

SILO (silopharma.com) - tandha merek perusahaan

Silo Pharma, Inc. (SILO) operates in the mental health niche, facing revenue deficits and a reliance on investment. On GURU.Markets, the actual gross margin is available as a trend, and this metric has reached the level of -1356.70. Growth potential is driven by academic partnerships to develop dementia therapies and professional management focused on clinical trial transparency and regulatory standards.

Tingkat bathi miturut bathi reged: silopharma.com (SILO) kanggo 28.04.2023 - 20.11.2026

Rincian metrik keuangan lan pasar Silo Pharma (SILO)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:Silo Pharma, Inc.
Sampel barang silopharma.com

High R&D expenditures and patent protection for Silo Pharma, Inc. (SILO) subnasal products drive gross margin volatility. This indicator captures the portion of revenue remaining after covering direct production costs, reflecting the business's operational efficiency. The percentage difference between total revenue and the cost of goods sold allows for an assessment of the fundamental stability of this high-risk biopharmaceutical asset.